NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $32,000 | -70.4% | 5,973 | -25.3% | 0.00% | -66.7% |
| Q4 2021 | $108,000 | -24.5% | 8,000 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $143,000 | +7050.0% | 8,000 | +5494.4% | 0.01% | – |
| Q3 2020 | $2,000 | -33.3% | 143 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | -99.8% | 143 | +45.9% | 0.00% | – |
| Q1 2020 | $1,749,000 | -80.8% | 98 | -76.8% | 0.00% | -100.0% |
| Q4 2019 | $9,130,000 | +18.5% | 423 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,704,000 | – | 423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |